We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe use of combination therapy is increasingly becoming the standard of care in oncology as cancers ...
Read moreThe QALY Shortfall aims to capture and recognise disease severity by assessing the degree of quality...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreInsights from pharmaceuticals, market access and Team Remap Q3 2021.
Read moreThe introduction of new medicines in England requires the cooperation of industry and the NHS.
Read moreNICE is increasing opportunities for patient engagement by simplifying the process and increasing pa...
Read moreNICE’s remodel plans focus on delivering faster and fairer access to treatments by optimising appr...
Read moreITC can provide an estimate of the relative treatment effect of two products that have not been comp...
Read moreThe agreement sets out to leverage the strengths of both organisations in embedding evidence-based h...
Read more